Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation

被引:58
|
作者
Khazanie, Prateeti [1 ,2 ]
Liang, Li [1 ]
Qualls, Laura G. [1 ]
Curtis, Lesley H. [1 ,2 ]
Fonarow, Gregg C. [3 ]
Hammill, Bradley G. [1 ,4 ]
Hammill, Stephen C.
Heidenreich, Paul A. [5 ]
Masoudi, Frederick A. [6 ]
Hernandez, Adrian F. [1 ,2 ]
Piccini, Jonathan P. [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[3] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
[4] Mayo Clin, Rochester, MN USA
[5] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[6] Univ Colorado, Aurora, CO USA
基金
美国医疗保健研究与质量局;
关键词
atrial fibrillation; heart failure; Medicare; mortality outcome; assessment (health care); patient readmission; VENTRICULAR SYSTOLIC DYSFUNCTION; PROFILING HOSPITAL PERFORMANCE; OPTIMIZE-HF; MORTALITY; RISK; REGISTRY; STROKE; READMISSION; RIVAROXABAN; PROGRESSION;
D O I
10.1016/j.jchf.2013.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study sought to examine the long-term outcomes of patients hospitalized with heart failure and atrial fibrillation. Background Atrial fibrillation is common among patients hospitalized with heart failure. Associations of pre-existing and new-onset atrial fibrillation with long-term outcomes are unclear. Methods We analyzed 27,829 heart failure admissions between 2006 and 2008 at 281 hospitals in the American Heart Association's Get With The Guidelines-Heart Failure program linked with Medicare claims. Patients were classified as having pre-existing, new-onset, or no atrial fibrillation. Cox proportional hazards models were used to identify factors that were independently associated with all-cause mortality, all-cause readmission, and readmission for heart failure, stroke, and other cardiovascular disease at 1 and 3 years. Results After multivariable adjustment, pre-existing atrial fibrillation was associated with greater 3-year risks of all-cause mortality (hazard ratio [HR]: 1.14 [99% confidence interval (CI): 1.08 to 1.20]), all-cause readmission (HR: 1.09 [99% CI: 1.05 to 1.14]), heart failure readmission (HR: 1.15 [99% CI: 1.08 to 1.21]), and stroke readmission (HR: 1.20 [99% CI: 1.01 to 1.41]), compared with no atrial fibrillation. There was also a greater hazard of mortality at 1 year among patients with new-onset atrial fibrillation (HR: 1.12 [99% CI: 1.01 to 1.24]). Compared with no atrial fibrillation, newonset atrial fibrillation was not associated with a greater risk of the readmission outcomes. Stroke readmission rates at 1 year were just as high for patients with preserved ejection fraction as for patients with reduced ejection fraction. Conclusions Both pre-existing and new-onset atrial fibrillation were associated with greater long-term mortality among older patients with heart failure. Pre-existing atrial fibrillation was associated with greater risk of readmission. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [41] Atrial fibrillation in heart failure
    Havmöller R.
    Chugh S.S.
    [J]. Current Heart Failure Reports, 2012, 9 (4) : 309 - 318
  • [42] Atrial Fibrillation and Heart Failure
    Hofmann, R.
    [J]. JOURNAL FUR KARDIOLOGIE, 2010, 17 : 8 - 10
  • [43] CHRONIC ALPHA BLOCKER USE AND OUTCOMES IN OLDER MALE MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE
    Dooley, Daniel
    Lam, Phillip
    Tomer, Meenakshi
    Arundel, Cherinne
    Gannuscio, Jacqueline
    Bayoumi, Essraa
    Segal, Jonathan
    Blackman, Marc
    Fonarow, Gregg
    Deedwania, Prakash C.
    White, Michel
    Butler, Javed
    Aronow, Wilbert
    Allman, Richard
    Ahmed, Ali
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 915 - 915
  • [44] Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
    Briasoulis, Alexandros
    Inampudi, Chakradhari
    Akintoye, Emmanuel
    Alvarez, Paulino
    Panaich, Sidakpal
    Vaughan-Sarrazin, Mary
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [45] Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
    Atwater, Brett D.
    Guo, Jennifer D.
    Keshishian, Allison
    Delinger, Rachel
    Russ, Cristina
    Rosenblatt, Lisa
    Jiang, Jenny
    Yuce, Huseyin
    Ferri, Mauricio
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (01) : 1 - 10
  • [46] Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
    Brett D. Atwater
    Jennifer D. Guo
    Allison Keshishian
    Rachel Delinger
    Cristina Russ
    Lisa Rosenblatt
    Jenny Jiang
    Huseyin Yuce
    Mauricio Ferri
    [J]. Journal of Thrombosis and Thrombolysis, 2024, 57 : 1 - 10
  • [47] Sleep Apnea Testing and Outcomes in a Large Cohort of Medicare Beneficiaries with Newly Diagnosed Heart Failure
    Javaheri, Shahrokh
    Ben Caref, E.
    Chen, Er
    Tong, Kuo Bianchini
    Abraham, William T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (04) : 539 - 546
  • [48] Sleep Apnea Testing and Outcomes in a Large Cohort of Medicare Beneficiaries with Newly Diagnosed Heart Failure
    Abraham, William T.
    Javaheri, Shahrokh
    [J]. JOURNAL OF CARDIAC FAILURE, 2009, 15 (06) : S79 - S79
  • [49] Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations
    Luo, Nancy
    Hammill, Bradley G.
    DeVore, Adam D.
    Xu, Haolin
    Fonarow, Gregg C.
    Albert, Nancy M.
    Matsouaka, Roland A.
    Hernandez, Adrian F.
    Yancy, Clyde
    Mentz, Robert J.
    [J]. AMERICAN HEART JOURNAL, 2020, 226 : 13 - 23
  • [50] Heart failure disease management strategies in medicare beneficiaries with heart failure are cost effective
    Sun, Sanjeev
    Usmani, Ali
    Fu, Zhenghong
    Phillips, Christopher O.
    [J]. CIRCULATION, 2007, 116 (16) : 736 - 736